Literature DB >> 27862856

Liver stiffness and platelet count for identifying patients with compensated liver disease at low risk of variceal bleeding.

Astrid Marot1, Eric Trépo2,3, Christopher Doerig1, Alain Schoepfer1, Christophe Moreno2,3, Pierre Deltenre1,2.   

Abstract

BACKGROUND & AIMS: The 2015 Baveno VI guidelines recommend against performing upper gastrointestinal endoscopy in patients with compensated cirrhosis who have a liver stiffness <20 kPa and a platelet count >150 000/mm³ because of a low prevalence of varices at risk of bleeding in this population. The aim was to synthesize the available evidence on the usefulness of the combined use of liver stiffness and platelet count to identify patients without oesophageal varices.
METHODS: Meta-analysis of trials evaluating the usefulness of a given cut-off for liver stiffness and platelet count to rule out the presence of oesophageal varices.
RESULTS: Fifteen studies were included. All studies excepting five used the Baveno VI criteria. Compared to patients with either high liver stiffness or low platelet count, those with low liver stiffness and normal platelet count had a lower risk of varices at risk of bleeding (OR=0.22, 95% CI=0.13-0.39, P<.001) with low heterogeneity between studies (I2 =21%). They also had a lower risk of varices (OR=0.23, 95% CI=0.17-0.32, P<.001) with moderate heterogeneity between studies (I2 =28%). In patients with low liver stiffness and normal platelet count, the pooled estimate rates for varices at risk of bleeding was 0.040 (95% CI=0.027-0.059) with low heterogeneity between studies (I2 =3%).
CONCLUSIONS: Patients with low liver stiffness and normal platelet count have a lower risk of varices than those with either high liver stiffness or low platelet count. Varices at risk of bleeding are found in no more than 4% of patients when liver stiffness is <20 kPa and platelet count is normal.
© 2016 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Child-Pugh score; cirrhosis; liver stiffness; oesophageal varices; platelets count; portal hypertension

Mesh:

Year:  2016        PMID: 27862856     DOI: 10.1111/liv.13318

Source DB:  PubMed          Journal:  Liver Int        ISSN: 1478-3223            Impact factor:   5.828


  21 in total

Review 1.  Remaining challenges for the noninvasive diagnosis of esophageal varices in liver cirrhosis.

Authors:  Tetsuo Takehara; Ryotaro Sakamori
Journal:  Esophagus       Date:  2019-10-16       Impact factor: 4.230

2.  Role of Spleen Stiffness Measurement by 2D-Shear Wave Elastography in Ruling Out the Presence of High-Risk Varices in Cirrhotic Patients.

Authors:  Dimitrios S Karagiannakis; Theodoros Voulgaris; Evgenia Koureta; Elissavet Chloupi; George V Papatheodoridis; John Vlachogiannakos
Journal:  Dig Dis Sci       Date:  2019-04-15       Impact factor: 3.199

3.  A Liver Stiffness Measurement-Based Nomogram Predicts Variceal Rebleeding in Hepatitis B-Related Cirrhosis.

Authors:  Linxiang Liu; Qi Liu; Nanxi Xiao; Yue Zhang; Yuan Nie; Xuan Zhu
Journal:  Dis Markers       Date:  2022-06-02       Impact factor: 3.464

Review 4.  Liver transplantation for alcoholic hepatitis: A systematic review with meta-analysis.

Authors:  Astrid Marot; Margaux Dubois; Eric Trépo; Christophe Moreno; Pierre Deltenre
Journal:  PLoS One       Date:  2018-01-11       Impact factor: 3.240

Review 5.  Noninvasive Assessment of Portal Hypertension in Advanced Chronic Liver Disease: An Update.

Authors:  Federico Ravaioli; Marco Montagnani; Andrea Lisotti; Davide Festi; Giuseppe Mazzella; Francesco Azzaroli
Journal:  Gastroenterol Res Pract       Date:  2018-06-07       Impact factor: 2.260

Review 6.  Small Esophageal Varices in Patients with Cirrhosis-Should We Treat Them?

Authors:  Thomas Reiberger; Theresa Bucsics; Rafael Paternostro; Nikolaus Pfisterer; Florian Riedl; Mattias Mandorfer
Journal:  Curr Hepatol Rep       Date:  2018-11-07

7.  SVR12 Higher than 97% in GT3 Cirrhotic Patients with Evidence of Portal Hypertension Treated with SOF/VEL without Ribavirin: A Nation-Wide Cohort Study.

Authors:  Alessandra Mangia; Giovanni Cenderello; Massimiliano Copetti; Gabriella Verucchi; Valeria Piazzolla; Celeste Lorusso; Rosanna Santoro; Maria Maddalena Squillante; Alessandra Orlandini; Rosalba Minisini; Alessia Ciancio
Journal:  Cells       Date:  2019-04-04       Impact factor: 6.600

Review 8.  Νon-invasive screening for esophageal varices in patients with liver cirrhosis.

Authors:  Andreas Karatzas; Christos Konstantakis; Ioanna Aggeletopoulou; Christina Kalogeropoulou; Konstantinos Thomopoulos; Christos Triantos
Journal:  Ann Gastroenterol       Date:  2018-03-03

9.  Application of Baveno Criteria and Modified Baveno Criteria with Shear-wave Elastography in Compensated Advanced Chronic Liver Disease.

Authors:  Seong Hee Kang; Soon Koo Baik; Moon Young Kim
Journal:  J Korean Med Sci       Date:  2020-08-03       Impact factor: 2.153

10.  Real-World Clinical Efficacy and Tolerability of Direct-Acting Antivirals in Hepatitis C Monoinfection Compared to Hepatitis C/Human Immunodeficiency Virus Coinfection in a Community Care Setting.

Authors:  Vijay Gayam; Muhammad Rajib Hossain; Mazin Khalid; Sandipan Chakaraborty; Osama Mukhtar; Sumit Dahal; Amrendra Kumar Mandal; Arshpal Gill; Pavani Garlapati; Sreedevi Ramakrishnaiah; Khalid Mowyad; Jagannath Sherigar; Mohammed Mansour; Smruti Mohanty
Journal:  Gut Liver       Date:  2018-11-15       Impact factor: 4.519

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.